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Improving the identification and treatment of sepsis
through a pediatric sepsis screening tool
Michael D. Pujol BSN, RN, CPEN, EMT-P; Tanya Cohn PhD, MEd, RN; Julie Lamoureux MSc DMD.;
Andrea Prentiss PhD, RN, CNS-BC, APRN-BC, CCRN; Martin Nariznis

Purpose
It is critical for sepsis screening to be
implemented and studied to identify possible
sepsis in the pediatric population. Currently
many acute care settings use an adult based
screening tool for all populations. This study
proposed that a new pediatric specific sepsis
screen should be utilized in comparison with
the previous tool to address the need for
improving identification of sepsis. Therefore,
the specific purpose of this study is to
determine if the implementation of an
evidence-based, pediatric specific sepsis
screening tool improved the identification of
sepsis in pediatric emergency department
patients.

Methods
Data was collected retrospectively from
sample of 0-17 years old, receiving a
diagnosis of sepsis, and treated within
Baptist Health South Florida between Oct.
2014-Oct.2015. The electronic medical
record screen and the Pediatric Sepsis ACT
tool were used to determine positive and
negative values of sepsis. Time of antibiotic
administration along with IVF bolus with type
was collected. Laboratory studies, including
blood cultures, procalcitonin, lactic acid,
WBC, and CRP were collected.

Discussion
 This will be a quasi-experimental study design with
a goal of 60 patients about to undergo surgical or
invasive procedures requiring an IV catheter
insertion in the pre op department at West Kendall
Baptist Hospital (WKBH).
 Patient who receive, as standard of practice, 1%
licocaine prior to IV insertion Will be compared to
those that did not.
 The study sample will consist of 60 patients aged 18
years and older

Our findings suggest that many of the
pediatric patients diagnosed with sepsis do
not fall into a category of severe sepsis in
need of aggressive lab and fluid treatment.
This may be the cause for less than half of
patients receiving blood cultures prior to
administration of antibiotics and minimal
collection of lab values. Findings also
demonstrated compliance issues from
nurses with about 1 of 5 patients not
receiving screening.

 To be included in the study participants have to
have IV accesses established, and the ability to
express their pain level.

Findings
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417 patients
had a positive result indicating
a low sensitivity of the screening process.
Only 40% of patients receiving antibiotics
had blood cultures collected prior to
medication administration with 27%
receiving intravenous fluids. 50% of the
patients had white blood cells measured.
Furthermore, the ACT part 1 screening tool
revealed 26% of those screened having a
positive result. This is in comparison to only
24% of the patients screened with the tsystem tool.

Implications for Practice
Nurses must be vigilant in screening the
pediatric population for sepsis. No significant
difference found between two screening
tools, however, it is recommended for
improvements to ensure proper compliance
of screening for at-risk pediatric patients.

